medications approved by the FDA for the treatment of common hair loss (androgenetic alopecia). These are the oral medication Propecia (which contains finasteride 1mg) and the topical medication Rogaine (that contains minoxidil).
Propecia® (finasteride 1mg) is an oral medication, manufactured by Merck Pharmaceuticals, that blocks the conversion of testosterone to dihydrotestosterone (DHT), the hormone largely responsible for male pattern baldness. It does this by inhibiting the action of the type II 5-alpha reductase enzyme that is present in higher concentration in and around the hair follicles of balding men with androgenetic alopecia. Finasteride is the only FDA approved medication for hair loss in men. It became available as the brand
c alopecia, nonresponsive to Minoxidil solution. After careful consideration and discussion with the patient, the decision was made to introduce oral finasteride at 1.25mg/day. After only 3.5 months of therapy there was a significant reduction in hair shedding and increased regrowth, without reported side effects. In addition, we present here a comprehensive review of the limited studies and case series that have thus far been reported using Finasteride to treat female androgenic alopecia.
POINT/COUNTERPOINT - International Society of Hair Restoration Surgery (ISHRS) Task Force on Finasteride Adverse Events 2015 At the ISHRS annual scientific meeting in Chicago, there was an excellent update on finasteride side effects by guest speaker and specialist in male infertility and sexual medicine, Dr. Mohit Khera, Associate Professor in the Department of Urology at Baylor College of Medicine.